EV/EBITDA
10.48
+0.10+0.96%
Fri, 29 Nov 2024 21:55:26 GMT
Summary:
Catalyst Pharmaceuticals EV/EBITDA is currently 10.48, with a rise of +0.10 (+0.96%) during the most recent trading day. Over the past year, it has dropped by -3.21 (-23.45%). CPRX EV/EBITDA is now -82.27% below its all-time high of 59.10.CPRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +1.0% |
| 1 m1 month | +4.3% |
| 3 m3 months | -37.2% |
| 6 m6 months | -27.0% |
| ytdytd | -23.9% |
| 1 y1 year | -23.4% |
| 5 y5 years | -77.8% |
CPRX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 11.63 | -9.9% | 9.52 | +10.1% |
| 3 m | 3 months | 17.69 | -40.8% | 8.84 | +18.6% |
| 6 m | 6 months | 17.69 | -40.8% | 8.84 | +18.6% |
| 1 y | 1 year | 17.69 | -40.8% | 8.84 | +18.6% |
| 3 y | 3 years | 21.17 | -50.5% | 6.86 | +52.8% |
| 5 y | 5 years | 48.01 | -78.2% | 4.68 | +123.9% |
| alltime | all time | 59.10 | -82.3% | -57.59 | +118.2% |
Catalyst Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 10.48(-23.9%) |
| 2023 | 13.78(-16.2%) |
| 2022 | 16.44(+63.1%) |
| 2021 | 10.08(+93.1%) |
| 2020 | 5.22(-44.1%) |
| 2019 | 9.34(-282.1%) |
| 2018 | -5.13(-72.2%) |
| 2017 | -18.43(+383.7%) |
| 2016 | -3.81(-55.6%) |
| Date | Value |
|---|---|
| 2015 | -8.58(-36.3%) |
| 2014 | -13.47(+34.2%) |
| 2013 | -10.04(+210.8%) |
| 2012 | -3.23(-24.5%) |
| 2011 | -4.28(+24.8%) |
| 2010 | -3.43(+600.0%) |
| 2009 | -0.49(-60.8%) |
| 2008 | -1.25(-77.0%) |
| 2007 | -5.44(-64.9%) |
| 2006 | -15.50 |
FAQ
- What is Catalyst Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Catalyst Pharmaceuticals?
- What is CPRX EV/EBITDA year-to-date change?
- What is Catalyst Pharmaceuticals EV/EBITDA year-on-year change?
What is Catalyst Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of CPRX is 10.48
What is the all time high EV/EBITDA for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high EV/EBITDA is 59.10
What is CPRX EV/EBITDA year-to-date change?
Catalyst Pharmaceuticals EV/EBITDA has changed by -3.30 (-23.95%) since the beginning of the year
What is Catalyst Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, CPRX EV/EBITDA has changed by -3.21 (-23.45%)